Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique.
暂无分享,去创建一个
Benedick A Fraass | Randall K Ten Haken | Marc L Kessler | Olivier Chapet | R. T. Ten Haken | M. Kessler | B. Fraass | O. Chapet | E. Thomas | Emma Thomas
[1] M. Goitein,et al. Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.
[2] John W Wong,et al. Validation of active breathing control in patients with non-small-cell lung cancer to be treated with CHARTWEL. , 2003, International journal of radiation oncology, biology, physics.
[3] James M Balter,et al. Daily targeting of intrahepatic tumors for radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[4] M. Roach,et al. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. , 1999, International journal of radiation oncology, biology, physics.
[5] H. Choy,et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R K Ten Haken,et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[7] Avraham Eisbruch,et al. Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: incorporating clinical decisions in the optimization process. , 2003, International journal of radiation oncology, biology, physics.
[8] Kunihiko Kobayashi,et al. Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer. , 2004, Lung cancer.
[9] Kai-Liang Wu,et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. , 2003, International journal of radiation oncology, biology, physics.
[10] Joos V Lebesque,et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. , 2003, International journal of radiation oncology, biology, physics.
[11] José Belderbos,et al. Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis , 2003 .
[12] M. Socinski,et al. Dose‐escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma , 2001, Cancer.
[13] C. Ling,et al. Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. , 2000, International journal of radiation oncology, biology, physics.
[14] H. Bartelink,et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.
[15] Indrin J Chetty,et al. Photon beam relative dose validation of the DPM Monte Carlo code in lung-equivalent media. , 2003, Medical physics.
[16] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D L McShan,et al. Is uniform target dose possible in IMRT plans in the head and neck? , 2002, International journal of radiation oncology, biology, physics.
[18] Y. Ung,et al. Reproducibility of lung tumor position and reduction of lung mass within the planning target volume using active breathing control (ABC). , 2003, International journal of radiation oncology, biology, physics.
[19] J. Deasy. Partial tumor boosts: even more attractive than theory predicts? , 2001, International journal of radiation oncology, biology, physics.
[20] Joseph O Deasy,et al. The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning. , 2002, Physics in medicine and biology.
[21] G J Kutcher,et al. Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. , 1999, International journal of radiation oncology, biology, physics.
[22] W. Curran,et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Socinski,et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial. , 2002, International journal of radiation oncology, biology, physics.
[24] A. Niemierko. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.
[25] Marina A. Epelman,et al. Costlets: A Generalized Approach to Cost Functions for Automated Optimization of IMRT Treatment Plans , 2005 .
[26] M. Martel,et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.
[27] R. Komaki,et al. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report. , 1998, International journal of radiation oncology, biology, physics.
[28] J. Fowler,et al. Selective boosting of tumor subvolumes. , 2000, International journal of radiation oncology, biology, physics.
[29] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[30] C. Ling,et al. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. , 2000, Cancer journal.
[31] D. Galetta,et al. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] L. Boersma,et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] A. Brugarolas,et al. Induction platinum-based chemotherapy followed by radical hyperfractionated radiotherapy with concurrent chemotherapy in the treatment of locally advanced non-small-cell carcinoma of the lung. , 1999, American journal of clinical oncology.
[34] Woo Sung Kim,et al. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer. , 2003, International journal of radiation oncology, biology, physics.
[35] J. Doroshow,et al. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] C C Ling,et al. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. , 2000, International journal of radiation oncology, biology, physics.
[37] R. Mohan,et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. , 2002, International journal of radiation oncology, biology, physics.
[38] E. Tan,et al. Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer. , 1999, Acta oncologica.
[39] J. Lyman. Complication Probability as Assessed from Dose-Volume Histograms , 1985 .
[40] J. Wong,et al. The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.
[41] R. Arriagada,et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.
[42] J. Battista,et al. A convolution method of calculating dose for 15-MV x rays. , 1985, Medical physics.
[43] M. V. van Herk,et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[44] H. Choy,et al. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] T. Bortfeld,et al. From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning. , 2003, Medical physics.